Safety evaluation of an extension of use of the food enzyme containing endo-1,3(4)-β-glucanase, endo-1,4-β-xylanase and cellulase activities from the non-genetically modified Mycothermus thermophiloides strain NZYM-ST
The food enzyme containing endo‐1,3(4)‐β‐glucanase (3‐(1,3;1,4)‐β‐d‐glucan 3(4)‐glucanohydrolase, EC 3.2.1.6), endo‐1,4‐β‐xylanase (4‐β‐d‐xylan xylanohydrolase, EC 3.2.1.8) and cellulase (4‐(1,3;1,4)‐β‐d‐glucan‐4‐glucanohydrolase, EC 3.2.1.4) activities is produced with the non‐genetically modified Mycothermus thermophiloides strain NZYM‐ST by Novozymes A/S. The safety of this food enzyme was evaluated previously, and it did not give rise to safety concerns when used in two food manufacturing processes.
Read the official notice →Source: EFSA (European Food Safety Authority) · EFSA reuse policy (attribution). This is a short, attributed summary; the full authoritative text lives on the authority’s own site. LabelYog does not author or endorse it — confirm compliance against the destination market’s official source.
More from European Union
- Safety of Acheta domesticus (house cricket) spray-dried powder as a Novel food pursuant to Regulation (EU) 2015/2283 regulatory
- Modification of the existing maximum residue level for ethofumesate in carrots regulatory
- Evaluation of confirmatory data following the Article 12 MRL review for quinmerac regulatory
- Safety evaluation of an extension of use of the food enzyme α-amylase from the genetically modified Bacillus licheniformis strain NZYM-KE regulatory
- Safety evaluation of an extension of use of the food enzyme α-amylase from the genetically modified Aspergillus niger strain NZYM-MC regulatory
- preDQ - Update & Upgrade Update and maintenance of the preDQ - software tool for peptide binding prediction to HLA-DQ2 and HLA-DQ8 regulatory
What this means for your label
A notice like this changes what a pack must carry. These are the rules we build against, starting with EU 1169.